[HTML][HTML] Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and …
M Huhn, A Nikolakopoulou, J Schneider-Thoma… - The Lancet, 2019 - thelancet.com
Background Schizophrenia is one of the most common, burdensome, and costly psychiatric
disorders in adults worldwide. Antipsychotic drugs are its treatment of choice, but there is …
disorders in adults worldwide. Antipsychotic drugs are its treatment of choice, but there is …
[HTML][HTML] Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017
C Hiemke, N Bergemann, HW Clement… - …, 2018 - thieme-connect.com
Therapeutic drug monitoring (TDM) is the quantification and interpretation of drug
concentrations in blood to optimize pharmacotherapy. It considers the interindividual …
concentrations in blood to optimize pharmacotherapy. It considers the interindividual …
[HTML][HTML] Half a century of research on antipsychotics and schizophrenia: A scientometric study of hotspots, nodes, bursts, and trends
Abstract Changes over 50 years of research on antipsychotics in schizophrenia have
occurred. A scientometric synthesis of such changes over time and a measure of …
occurred. A scientometric synthesis of such changes over time and a measure of …
Transdiagnostic psychiatry: a systematic review
The usefulness of current psychiatric classification, which is based on ICD/DSM categorical
diagnoses, remains questionable. A promising alternative has been put forward as the …
diagnoses, remains questionable. A promising alternative has been put forward as the …
Management of common adverse effects of antipsychotic medications
TS Stroup, N Gray - World Psychiatry, 2018 - Wiley Online Library
The benefits of antipsychotic medications are sometimes obscured by their adverse effects.
These effects range from relatively minor tolerability issues (eg, mild sedation or dry mouth) …
These effects range from relatively minor tolerability issues (eg, mild sedation or dry mouth) …
[HTML][HTML] Master protocols to study multiple therapies, multiple diseases, or both
J Woodcock, LM LaVange - New England Journal of Medicine, 2017 - Mass Medical Soc
Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both | NEJM Skip to main
content NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to …
content NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to …
[PDF][PDF] Obesity: definition, comorbidities, causes, and burden
CM Apovian - Am J Manag Care, 2016 - ajmc.s3.amazonaws.com
Body mass index of 30 kg/m2 or higher is used to identify individuals with obesity. In the last
3 decades, the worldwide prevalence of obesity has increased 27.5% for adults and 47.1 …
3 decades, the worldwide prevalence of obesity has increased 27.5% for adults and 47.1 …
EPA guidance on assessment of negative symptoms in schizophrenia
BackgroundDuring the last decades, a renewed interest for negative symptoms (NS) was
brought about by the increased awareness that they interfere severely with real-life …
brought about by the increased awareness that they interfere severely with real-life …
Antipsychotics: mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology
SJ Kaar, S Natesan, R Mccutcheon, OD Howes - Neuropharmacology, 2020 - Elsevier
Antipsychotic drugs are central to the treatment of schizophrenia and other psychotic
disorders but are ineffective for some patients and associated with side-effects and …
disorders but are ineffective for some patients and associated with side-effects and …
The polygenic architecture of schizophrenia—rethinking pathogenesis and nosology
Schizophrenia is a severe psychiatric disorder with considerable morbidity and mortality.
Although the past two decades have seen limited improvement in the treatment of …
Although the past two decades have seen limited improvement in the treatment of …